24 related articles for article (PubMed ID: 24068396)
1. Evaluation of allelic alterations in short tandem repeats in papillary thyroid cancer.
Dang Z; Li L; Kong X; Zhang G; Liu Q; Li H; Li L; Zhang R; Cui W; Wang Y
Mol Genet Genomic Med; 2020 Apr; 8(4):e1164. PubMed ID: 32043756
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of KDM1A suppresses tumour migration and invasion by epigenetically regulating the TIMP1/MMP9 pathway in papillary thyroid cancer.
Zhang W; Sun W; Qin Y; Wu C; He L; Zhang T; Shao L; Zhang H; Zhang P
J Cell Mol Med; 2019 Aug; 23(8):4933-4944. PubMed ID: 31211500
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of LSD1 suppresses the proliferation, tumorigenicity and invasion of papillary thyroid carcinoma K1 cells.
Kong LL; Man DM; Wang T; Zhang GA; Cui W
Oncol Lett; 2016 Apr; 11(4):2475-2480. PubMed ID: 27073501
[TBL] [Abstract][Full Text] [Related]
4. siRNA targeting RBP2 inhibits expression, proliferation, tumorigenicity and invasion in thyroid carcinoma cells.
Kong LL; Man DM; Wang T; Zhang GA; Cui W
Oncol Lett; 2015 Dec; 10(6):3393-3398. PubMed ID: 26788140
[TBL] [Abstract][Full Text] [Related]
5. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
Jiang XL; Zhang H; Chen YL; Peng L
Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
[No Abstract] [Full Text] [Related]
6. Prognostic significance of DLL4 expression in papillary thyroid cancer.
Zhang YZ; Qin F; Han ZG; Liu Q; Zhou L; Wang YW
Eur Rev Med Pharmacol Sci; 2015 Aug; 19(15):2901-5. PubMed ID: 26241546
[TBL] [Abstract][Full Text] [Related]
7. Associations of miR-146a and miR-146b expression and clinical characteristics in papillary thyroid carcinoma.
Sun M; Fang S; Li W; Li C; Wang L; Wang F; Wang Y
Cancer Biomark; 2015; 15(1):33-40. PubMed ID: 25524940
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical levels of cyclo-oxygenase-2, matrix metalloproteinase-9 and vascular endothelial growth factor in papillary thyroid carcinoma and their clinicopathological correlations.
Meng XY; Zhang Q; Li Q; Lin S; Li J
J Int Med Res; 2014 Jun; 42(3):619-27. PubMed ID: 24670538
[TBL] [Abstract][Full Text] [Related]
9. [The expression and clinical significance of EphA2 and E-cadherin in papillary thyroid carcinoma].
Liu Y; Miao Y; Li X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jun; 29(11):1020-3. PubMed ID: 26536708
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of RBP2 and LSD1 in papillary thyroid carcinoma.
Kong L; Zhang G; Wang X; Zhou J; Hou S; Cui W
Rom J Morphol Embryol; 2013; 54(3):499-503. PubMed ID: 24068396
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-146b: A Novel Biomarker and Therapeutic Target for Human Papillary Thyroid Cancer.
Chou CK; Liu RT; Kang HY
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28294980
[TBL] [Abstract][Full Text] [Related]
12. Cytomorphologic and molecular features of hobnail variant of papillary thyroid carcinoma: case series and literature review.
Asioli S; Maletta F; Pagni F; Pacchioni D; Vanzati A; Mariani S; Palestini N; Lloyd RV; Sapino A
Diagn Cytopathol; 2014 Jan; 42(1):78-84. PubMed ID: 23913779
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
